Tiny (“Tiny” or the “Company”) (TSXV: TINY) a
Canadian holding company and Dr. Andrew Huberman announce that
their majority owned Canadian Yerba Mate Beverage – Mateina –is now
available in the United States via drinkMateina.com. The U.S.
launch includes a new sugar-free option that was co-developed with
Dr. Huberman.
Tiny’s interest in Mateina is held through its private
partnership, Tiny Fund I, LP. Dr. Huberman is a neuroscientist and
professor in the department of neurobiology at Stanford School of
Medicine, and also one of the top podcasters in the world with the
Huberman Lab Podcast.
Mateina
Founded in 2017 by Nicolas Beaupré and Elodie Simard, Mateina
was born out of a lack of low-sugar and organic Yerba Mate options
in the market and is available across Canada at leading retailers
like Whole Foods. Cultivated in partnership with a
fourth-generation farming family in Misiones, Argentina, the brand
offers an array of organic, sustainably farmed yerba mate products.
These include non-carbonated, lightly sweetened cold beverages in a
variety of flavors (original lemon, peach passion, and grapefruit
guava), loose leaf teas, and a new sugar-free option. Nicolas
Beaupré and Elodie Simard, continue to operate the business while
leveraging the partnership with Tiny and Dr. Huberman.
Management Commentary
“We envision a world where yerba mate is a highly accessible and
health-forward beverage that is consumed by hundreds of millions of
people in the US and around the world, in the same way coffee and
tea are today," said Elodie Simard, co-founder of Mateina.
"Partnering with Tiny and Dr. Huberman enables us to introduce
Mateina U.S. and globally while also underscoring our commitment to
sustainable, organic farming practices in Argentina."
"Yerba mate has been my preferred source of caffeine for more
than three decades," said Dr. Huberman. "I often discuss yerba
mate's health benefits — emphasizing its high antioxidant content,
its role in managing blood sugar, and its possible neuroprotective
effects. Collaborating with Mateina to develop a non-smoked,
sugar-free version of cold pressed yerba mate was a thrill and I’m
so excited to be able to share this drink with the world. I see it
as a truly peerless beverage in terms of its positive effects on
mind and body."
Andrew Wilkinson, co-founder of Tiny, added, “Tiny has been a
huge supporter of Andrew Huberman and we are incredibly excited to
partner together on developing and bringing to market this
incredible yerba mate brand to the US. We're confident that Mateína
will make a significant impact in the U.S. health beverage market,
bolstered by Dr. Huberman's expertise and the scientific merits of
yerba mate."
About Mateina
Mateina is devoted to delivering high-quality, organic yerba
mate beverages. Upholding a strong commitment to sustainability,
the company sources its yerba mate directly from family-owned farms
in Argentina. The product range, which includes sugar-free and
low-sugar options, combines the health benefits of yerba mate with
the deep cultural heritage of South America, introducing a novel
approach to the energy drink landscape. For more information, visit
drinkMateina.com.
About Dr. Andrew Huberman & Huberman Lab
Andrew Huberman, Ph.D., is a neuroscientist and tenured
professor in the department of neurobiology, and by courtesy,
psychiatry and behavioral sciences at Stanford School of Medicine.
He has made numerous significant contributions to the fields of
brain development, brain function and neural plasticity, which is
the ability of our nervous system to rewire and learn new
behaviors, skills and cognitive functioning.
Huberman is a McKnight Foundation and Pew Foundation Fellow and
was awarded the Cogan Award in 2017, given to the scientist making
the most significant discoveries in the study of vision. His lab’s
most recent work focuses on the influence of vision and respiration
on brain states such as fear and high attention focus and
developing rapid and effective tools for mitigating stress and
improving sleep and other physiological metrics.
Work from the Huberman Laboratory at Stanford School of Medicine
has been published in top journals including Nature, Science and
Cell and has been featured in TIME, BBC, Scientific American,
Discover and other top media outlets.
In 2021, Dr. Huberman launched the Huberman Lab podcast. The
podcast is frequently ranked in the top 10 of all podcasts globally
and is often ranked #1 in the categories of Science, Education, and
Health & Fitness.
Alongside hosting the Huberman Lab podcast, Andrew Huberman is
the co-founder of Scicomm Media.
For more information about Huberman Lab, please visit
www.hubermanlab.com. For more information about Scicomm Media,
please visit www.scicommedia.com.
About Tiny
Tiny is a Canadian-based investment company focused primarily on
investing and acquiring majority stakes in businesses that it
expects to hold over the long-term. The Company is structured to
give maximum flexibility to operating management teams by
maintaining a focus at the parent company level on only three
areas: capital allocation, management, and incentives. This
structure enables each company to run independently and focus on
what they do best, within an incentive structure that is designed
to drive results for both the operating business and ultimately for
Tiny and its shareholders.
Tiny currently has three principle reporting segments: Digital
Services, which provides design, engineering, brand positioning and
marketing services to help companies of all sizes deliver premium
web and mobile products; E-Commerce Platform, which is home to a
complementary portfolio of recurring revenue software businesses
that support merchants, as well as digital themes businesses that
sell templates to Shopify merchants; and Creative Platform, which
is comprised primarily of Dribbble, the leading social network for
designers and digital creatives, as well as a premier online
marketplace for digital assets such as fonts and templates.
For more information, please visit www.tiny.com or refer to the
public disclosure documents available under Tiny’s SEDAR+ profile
at www.sedarplus.ca.
Cautionary Note Regarding Forward-Looking
Information:
This press release contains statements which constitute
“forward-looking statements” and “forward-looking information”
within the meaning of applicable securities laws (collectively,
“forward-looking statements”), including statements regarding the
plans, intentions, beliefs and current expectations of the Company
with respect to future business activities and operating
performance. Forward-looking statements are often identified by the
words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”,
“anticipate”, “believe”, “estimate”, “expect” or similar
expressions and forward-looking statements in this press release
includes, but is not limited to, information and statements
regarding the completion of the transaction and the timing thereof
and Company's beliefs regarding the future prospects of
Mateina.
Investors are cautioned that forward-looking statements are not
based on historical facts but instead reflect the Company’s
expectations, estimates or projections concerning future results or
events based on the opinions, assumptions and estimates of
management considered reasonable at the date the statements are
made. Although the Company believes that the expectations reflected
in such forward-looking statements are reasonable, such statements
involve risks and uncertainties, and undue reliance should not be
placed thereon, as unknown or unpredictable factors could have
material adverse effects on future results, performance or
achievements of the Company.
Among the key factors that could cause actual results to differ
materially from those projected in the forward-looking statements
are the following: changes in general economic, business and
political conditions, including challenging global financial
conditions and the impact of the novel coronavirus pandemic;
competition risks; potential conflicts of interest; changes in
applicable laws and regulations both locally and in foreign
jurisdictions; compliance with extensive government regulation; and
the risks and uncertainties associated with foreign markets.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking statements
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended and
such changes could be material. The Company does not intend, and
does not assume any obligation, to update the forward-looking
statements except as otherwise required by applicable law.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240125911476/en/
David Charron Chief Financial Officer Phone: 416-418-3881 Email:
david@tiny.com
Proshares Nanotechnology... (AMEX:TINY)
過去 株価チャート
から 11 2024 まで 12 2024
Proshares Nanotechnology... (AMEX:TINY)
過去 株価チャート
から 12 2023 まで 12 2024
